Concepedia

Publication | Open Access

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

91

Citations

35

References

2023

Year

References

YearCitations

Page 1